These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 2707311)

  • 1. Comparative effects of almitrine and raubasine, singly and in combination, on electroencephalographic activity in young and old rats.
    Sebban C; Tesolin B; Coulomb B; Berthaux P
    Exp Gerontol; 1989; 24(1):11-24. PubMed ID: 2707311
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A review of the EEG effects of the combination of almitrine and raubasine in animals and humans.
    Sebban C; Tesolin B; Schatz C; Malbezin M; Guez D
    Clin Neuropharmacol; 1990; 13 Suppl 3():S50-8. PubMed ID: 2093418
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Comparison of the effects of almitrine, raubasine and 5023 SE on arterial oxygen desaturation during exercise].
    Sebban C; Berthaux P
    Presse Med; 1983 Mar; 12(13):847-8. PubMed ID: 6220334
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Double-blind, placebo-controlled quantitative EEG and psychometric studies in elderlies on vigilance-promoting effects of an almitrine/raubasine combination (Duxil).
    Saletu B; Grünberger J; Linzmayer L; Anderer P
    Arch Gerontol Geriatr; 1988 Jun; 7(2):93-110. PubMed ID: 3415398
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Quantified electroencephalogram: value in the evaluation of therapy of cerebral aging].
    Sebban C; Tesolin B; Guez D
    Presse Med; 1987 Jun; 16(23):1154-8. PubMed ID: 2885826
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative electroencephalography in aging brain and cerebrovascular disease: the effects of almitrine-raubasine.
    Sebban C
    Eur Neurol; 1995; 35 Suppl 1():37-42. PubMed ID: 8529728
    [No Abstract]   [Full Text] [Related]  

  • 7. [Psychometric evaluation of the effects of an almitrine-raubasine combination in the intellectual deterioration of aged subjects. A double-blind controlled trial versus placebo].
    Rapisarda V; Azzaro E; Fichera G
    Presse Med; 1987 Jun; 16(23):1163-6. PubMed ID: 2885827
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Curative effect of an almitrine-raubasine combination in the postischemic syndrome following transient cerebral ischemia in dogs.
    Cahn R; Cahn J
    Pharmacology; 1988; 36(3):156-65. PubMed ID: 3368502
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Almitrine-raubasine and cognitive impairment in the elderly: results of a 6-month controlled multicenter study.
    Poitrenaud J; Piette F; Malbezin M; Sebban C; Guez D
    Clin Neuropharmacol; 1990; 13 Suppl 3():S100-8. PubMed ID: 2093414
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of a tissue oxygenator (almitrine + raubasine) on the metabolism of 2,3-diphosphoglycerate of rabbits submitted by hypoxia].
    Callis A; Dorance M; Magnan de Bornier B
    C R Seances Soc Biol Fil; 1980; 174(6):1006-9. PubMed ID: 6451260
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stability-indicating methods for the determination of a mixture of almitrine and raubasine by derivative spectrophotometry.
    El-Sayed MA
    Drug Test Anal; 2009 Jun; 1(6):279-85. PubMed ID: 20355207
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Exploration of the effects of duxil on the central nervous system by quantified electroencephalography].
    Sebban C
    Rev Med Interne; 1988 Feb; 9(1):58-62. PubMed ID: 3387703
    [No Abstract]   [Full Text] [Related]  

  • 13. Experimental approach of treatment of cerebral ischemia by a combination of raubasine and almitrine.
    Borzeix MG; Cahn J
    Arzneimittelforschung; 1987 May; 37(5):491-4. PubMed ID: 2887170
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of almitrine-raubasine in cognitive disorders of aging: a double-blind, placebo-controlled, clinical and psychometric study.
    Carbonin PU; Greco A; Pisanti P; Gemma A; Cattelin F
    Clin Neuropharmacol; 1990; 13 Suppl 3():S92-9. PubMed ID: 2093422
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological features of an almitrine-raubasine combination. Activity at cerebral levels.
    Benzi G
    Eur Neurol; 1998; 39 Suppl 1():31-8. PubMed ID: 9516073
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathophysiology of postischemic hypoxia and cerebral protection: implications of the almitrine and raubasine combination.
    Chan P
    Eur Neurol; 1995; 35 Suppl 1():23-7. PubMed ID: 8529726
    [No Abstract]   [Full Text] [Related]  

  • 17. [Effects of aging and various pharmacologic agents on the brain energy metabolism in the course of post-hypoglycemic recuperation in the rat].
    Villa RF; Pastoris O
    Presse Med; 1987 Jun; 16(23):1128-34. PubMed ID: 2885824
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of the therapeutic activity of a combination of almitrine and raubasine on functional rehabilitation following ischaemic stroke.
    Li S; Long J; Ma Z; Xu Z; Li J; Zhang Z
    Curr Med Res Opin; 2004 Mar; 20(3):409-15. PubMed ID: 15025850
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The influence of aging on cerebral energy metabolism following post-hypoglycemic recovery in the rat. Pharmacologic application].
    Villa RF; Pastoris O
    J Pharmacol; 1986; 17(4):623-36. PubMed ID: 3560973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term effects and safety of almitrine-raubasine in age-associated cognitive decline.
    Guez D
    Clin Neuropharmacol; 1990; 13 Suppl 3():S109-16. PubMed ID: 2093415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.